OSR1 and metabolic dysfunction-associated steatotic liver disease: Although obvious NASH was not observed after the 12-week treatment of HFD and DEN, a NASH CRN Scoring System was used to evaluate the NAFLD progression in the Osr1+/− and WT mice (Table 1) (33).